February 25, 2014 / 6:35 PM / 3 years ago

BRIEF-AstraZeneca says FDA approves drug for rare body fat disorder

Feb 25 (Reuters) - AstraZeneca PLC : * FDA approves orphan drug Myalept * Myalept, a recombinant analogue of human leptin, is the first and only treatment approved by the FDA for these patients * To make Myalept available to patients as soon as possible in the US. * Is working to complete transfer of the Biologics License Application (BLA) for Myalept from Bristol-Myers Squibb company to Astrazeneca * Source text for Eikon: * For more news, please click here

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below